Drug‐Induced Liver Injury by Selective Androgenic Receptor Modulators

Abstract

Selective androgenic receptor modulators (SARMs) have not been approved by the U.S. Food and Drug Administration but they are heavily promoted as alternatives to androgenic anabolic steroids. We present two cases of liver injury associated with SARMs.